Generic name: Almitrine/raubasine

Classification

Antiemetics & Antivertigo Drugs / Neurodegenerative Disease Drugs

Contents

Almitrine bismesylate 30 mg, raubasine 10 mg

Indications

Minor, age-related neurological disorders; same visual & inner ear disorders related to circulation.

Dosage

1 tab once or bid (taken separately). Max: 2 tab/day.

Adverse Reactions

Have been occasionally reported during long-term treatment: wt loss, peripheral neuropathy should lead to treatment w/drawal. Mild GI disorders, sleep disturbances, drowsiness, agitation, anxiety, palpitation, dizziness.

Interactions

MAOIs, other almitrine-containing prep.